Insider trade

Clarivate (CLVT): Director received 62K shares

Suzanne Heywood, Director at Clarivate, reported a grant / award of 62K shares.

62K
Shares
Traded
May 14, 2026
Filed
May 16, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Dec 31, 2025Federal contract · $5.9M obligatedDepartment of the Treasury awarded CLARIVATE PLC: $5.93M obligated to date
  2. Jan 28, 2026Federal contract · $1.3M obligatedDepartment of Commerce awarded CLARIVATE PLC: $1.29M obligated to date
  3. Feb 26, 2026Federal contract · $777K obligatedDepartment of Justice awarded CLARIVATE PLC: $777K obligated to date
  4. Mar 23, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On March 23, 2026, the Board of Directors (the “Board”) of Clarivate Plc (the “Company”), upon the recommendation of the Human Resources and Compensation Committee of the Board (the “HRCC”), approved the adoption of the Amended and Restated Executive Severance Plan of Clarivate Plc (the “A&R Executive Severance Plan”), effective March 23, 2026.”
  5. Mar 31, 2026Federal contract · $2.4M obligatedDepartment of Homeland Security awarded CLARIVATE PLC: $2.4M obligated to date
  6. Apr 2, 2026Federal contract · $5.4M obligatedDepartment of Homeland Security awarded CLARIVATE PLC: $5.44M obligated to date
  7. Apr 6, 2026Federal contract · $696K obligatedDepartment of Agriculture awarded CLARIVATE PLC: $696K obligated to date
  8. Apr 29, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors

What came next

  1. Jun 5, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“Maroun S. Mourad, President, Intellectual Property of Clarivate Plc (the “Company”) will depart from his position, effective June 9, 2026. Following such date, Mr. Mourad will remain employed by the Company in a non-executive advisory role until September 30, 2026.”
  2. Jul 3, 2026Company filing · Form 8-K · Material agreement, Executive changeChanged a top executive or board member, and signed an important agreement“On July 3, 2026, a subsidiary of Clarivate entered into a retention agreement with Henry Levy, Clarivate’s President, Life Sciences & Healthcare, to encourage his continued commitment toward the completion of the Transaction.”
  3. Jul 24, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On July 24, 2026, Jonathan Collins, the Executive Vice President & Chief Financial Officer of Clarivate Plc (the “Company”) resigned from his position, effective August 7, 2026.”
  4. Jul 29, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
  5. Aug 3, 2026Insider · 1 personInsiders: 3 sales (~$4.8M)
  6. Aug 6, 2026InsiderDirector purchased ~$1.21M of CLVT shares in the open market
  7. Aug 7, 2026InsiderDirector purchased ~$463K of CLVT shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Clarivate

For Clarivate, OQRO holds 4 insider filings (SEC Form 4 or Form 144) and 3 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CLVT page.

Other recent filings by Suzanne Heywood, Director

The full history of Suzanne Heywood, Director is on the profile page.

How this filing works

Explore the data

Common questions

Which Clarivate (CLVT) insider traded, and how much?

Suzanne Heywood, Director at Clarivate, reported a grant / award of 62K shares. Not an open-market trade.

When did it happen, and when was it made public?

Traded: May 14, 2026. Filed: May 16, 2026. That is 2 days between the two dates.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Clarivate recently?

For Clarivate, OQRO holds 4 insider filings (SEC Form 4 or Form 144) and 3 federal contract awards dated in the last 90 days. They are listed on the CLVT page.

Does this mean CLVT stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Clarivate

Everything OQRO holds on this company is on its CLVT page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data